Recombinant Human IL-2 (293E expressed, carrier-free) and 2 more items
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0457399
- Awardee
- BIOLEGEND INC.
- Contracting organization
- University of Virginia
- Cumulative value
- $807.50
About this award
The University of Virginia has awarded contract A207_PO-0457399 to BioLegend Inc., a prime contractor specializing in life science research products. This purchase order, effective July 11, 2026, is valued at $807 and encompasses three distinct recombinant protein and reagent products for delivery to Rahul Sharma at the University of Virginia in Virginia.
The contract specifies three line items: Recombinant Human Interleukin-2 (IL-2) expressed in 293E cells at a unit price of $276.50, Recombinant Human Interleukin-33 (IL-33) as a carrier-free formulation at $283.50 per unit, and MojoSort™ Streptavidin Nanobead reagent at $247.50 per unit. Each item is procured as a single unit, with all products designated as carrier-free formulations suitable for research applications. These biologics and magnetic separation reagents are consistent with cell biology, immunology, or flow cytometry research protocols typically conducted within academic research institutions.
Line items
| Item | Total |
|---|---|
| Recombinant Human IL-2 (293E expressed, carrier-free) | $276.50 |
| Recombinant Human IL-33 (carrier-free) | $283.50 |
| MojoSortTM Streptavidin Nanobeads | $247.50 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0457399?
Contract A207_PO-0457399 was awarded to BIOLEGEND INC. by University of Virginia on July 11, 2026.
How much is contract A207_PO-0457399 worth?
Its cumulative value is $807.50.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award